Associate Attending – Radiation Oncology

Location: New York, NY · Type: Full time · Posted: 2026-09-11 · Closes: 2026-12-11 · Reference: 102473

About Us:

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe.

Exciting Opportunity at MSK: Associate Attending

Role Overview

Key Requirements

The Department of Radiation Oncology at Memorial Sloan Cancer Center (MSKCC) is seeking a qualified Radiation Oncologist candidate for the position of Director, Metastatic Disease Team.

The Metastatic Disease Team in the Department of Radiation Oncology at MSK focuses on the treatment of metastatic disease across primary tumor types. Since its inception in 2017, the team has developed a wide-ranging research portfolio of clinical, translational, and health services studies that examine the role of radiation in the context of metastatic disease. The group also has constructed clinical guidelines pertaining to the indications for radiation and the optimal techniques, including ablative regimens such as stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) in the context of metastases. It has collaborated closely with surgery, Anesthesia Pain, and Supportive care, Medical Oncology and Early Drug Development teams to initiate multidisciplinary clinics and research efforts. The Metastatic Director will oversee the clinical and research operations of this disease team, which involves approximately 20 faculty across disease sites.

The position will involve approximately 50% clinical effort, with a potential, partial focus on metastatic cancer, and 50% dedicated research time (pending the clinical or clinical-academic track). The research component of the role can be performed at any Memorial Sloan Kettering facility. Candidates in the research track would be expected to develop both clinical and translational research, such as clinical trials, biospecimen studies, patient-reported outcomes, and health services research.

The Department of Radiation Oncology at MSKCC treats approximately 14,500 patients across 7 locations, with 65 faculty members.

Submit C.V., letter of interest, and references in your application submission to:

Sean M McBride, MD, MPH, MSL; Vice Chair

[email protected]

Pay Range: $500,000 - $700,000

Helpful links:

Physician compensation is based on multiple variables. This range represents annual salary only and does not include supplemental performance-based pay or any one-time payments that eligible candidates may be offered at the time of hire.

Pay Range: $0.00 - $10,000,000.00

FSLA Status: Exempt

Closing :

At MSK, we believe in fair, competitive pay that reflects your job, experience, and skills.

MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.

Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.